Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone·1993·Nature
DOI 10.1038/362841a0

Cited by (1,006)

Items 601–700 of 1,006

  1. Active Immunization Against the Vascular Endothelial Growth Factor Receptor flk1 Inhibits Tumor Angiogenesis and Metastasis
    Yiwen Li, Mei-Nai Wang, Hongli Li, Karen D. King, Rajiv Bassi, Haijun Sun, Angel Santiago, Andrea T. Hooper, Peter Böhlen, Daniel J. Hicklin · 2002 · The Journal of Experimental Medicine
  2. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
    Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, Qing Liu, André Robidoux, Luis Báez-Díaz, Adam Brufsky, Rita S. Mehta, Louis Fehrenbacher et al. · 2015 · The Lancet Oncology
  3. Overcoming key biological barriers to cancer drug delivery and efficacy
    Susy M. Kim, Peggy Ho Faix, Jan E. Schnitzer · 2017 · Journal of Controlled Release
  4. Defective Function of Langerhans Cells in Tumor-Bearing Animals Is the Result of Defective Maturation from Hemopoietic Progenitors
    Tadao Ishida, Tsunehiro Oyama, David Paul Carbone, Dmitry I. Gabrilovich · 1998 · The Journal of Immunology
  5. The Role of the Tumor Microenvironment in Regulating Angiogenesis
    Randolph S. Watnick · 2012 · Cold Spring Harbor Perspectives in Medicine
  6. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    K. Jin Kim, Lihong Wang, Yi-Chi Su, G. Yancey Gillespie, Amandeep Salhotra, Bachchu Lal, John Laterra · 2006 · Clinical Cancer Research
  7. Characterization of single neurons reprogrammed by pancreatic cancer
    Vera Thiel, Simon Renders, Jasper Panten, Nicolas Dross, Katharina Bauer, Daniel Domínguez Azorín, Vanessa Henriques, Vanessa Vogel, Corinna Klein, Aino‐Maija Leppä et al. · 2025 · Nature
  8. VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth
    Ji Young Yoo, Joo-Hang Kim, Young‐Guen Kwon, Eok-Cheon Kim, Nam Kyu Kim, Hye Jin Choi, Chae‐Ok Yun · 2007 · Molecular Therapy
  9. The Rationale and Future Potential of Angiogenesis Inhibitors in Neoplasia
    Giampietro Gasparini · 1999 · Drugs
  10. Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism
    T Hawighorst, Paula Velasco, Michael Streit, Young‐Kwon Hong, Themis R. Kyriakides, Lawrence F. Brown, Paul Bornstein, Michael J. Detmar · 2001 · The EMBO Journal
  11. Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases
    Clara Lubeseder–Martellato, Eric Guenzi, Anita Jörg, Kristin Töpolt, Elisabeth Naschberger, Elisabeth Kremmer, Christian Zietz, Erwin Tschachler, Peter Hutzler, Martin Schwemmle et al. · 2002 · American Journal Of Pathology
  12. Potential roles for the PIM1 kinase in human cancer – A molecular and therapeutic appraisal
    Nilesh Shah, Brendan Pang, Khay Guan Yeoh, Shannon Thorn, Chien Shing Chen, Michael B. Lilly, Manuel Salto‐Tellez · 2008 · European Journal of Cancer
  13. A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
    Dezheng Dong, Christopher J. Stapleton, Biquan Luo, Shigang Xiong, Wei Ye, Yi Zhang, Niyati Jhaveri, Genyuan Zhu, Risheng Ye, Zhi Liu et al. · 2011 · Cancer Research
  14. Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis
    Bradley McColl, Steven A. Stacker, Marc G. Achen · 2004 · Apmis
  15. Antibody Humanization Using Monovalent Phage Display
    Manuel Baca, Leonard G. Presta, Shane J. O'Connor, James A. Wells · 1997 · Journal of Biological Chemistry
  16. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer
    Colleen M. Lennard, Aneeta D. Patel, John Wilson, Brian J. Reinhardt, Caroline Tuman, Cydney Fenton, Elizabeth Blair, Gary L. Francis, Robert Michael Tuttle · 2001 · Surgery
  17. Targeting PAK4 to reprogram the vascular microenvironment and improve CAR‐T immunotherapy for glioblastoma
    Ma, Wenjuan, Wang, Yanling, Zhang, Rongxin, Yang, Fan, Zhang, Duo, Huang, Menggui, Zhang, Lin, Dorsey, Jay F., Binder, Zev A., O’Rourke, Donald M. et al. · 2020 · Nature Cancer
  18. Bevacizumab and daily temozolomide for recurrent glioblastoma
    Annick Desjardins, David A. Reardon, April D. Sykes, Jennifer E. Marcello, James E. Herndon, Leighann Bailey, Katherine B. Peters, Henry S. Friedman, James J. Vredenburgh · 2011 · Cancer
  19. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
    Ewa Maj, Diana Papiernik, Joanna Wietrzyk · 2016 · International Journal of Oncology
  20. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo
    Gunter Schuch, Marcelle Machluf, Georg C. Bartsch, Masashi Nomi, Henri Richard, Anthony Atala, Shay Söker · 2002 · Blood
  21. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes
    Álvaro Aguayo, Hagop M. Kantarjian, Elihu H. Estey, Francis Joseph Giles, Srđan Verstovšek, Taghi Manshouri, C Gidel, Susan Mary O'Brien, Michael J. Keating, Maher X. Albitar · 2002 · Cancer
  22. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines
    Sylvie Lantuéjoul, Bruno Constantin, Harry A. Drabkin, Christian Brambilla, Joëlle Roche, Elisabeth M. Brambilla · 2003 · The Journal of Pathology
  23. Invasion as limitation to anti-angiogenic glioma therapy
    Katrin Lamszus, Philip Kunkel, Manfred Westphal · 2003 · Springer eBooks
  24. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
    Kazunari Koga, Tatemi Todaka, Motohiro Morioka, Jun‐ichiro Hamada, Yutaka Kai, Shigetoshi Yano, Akira Okamura, Nobuyuki Takakura, Toshio Suda, Yukitaka Ushio · 2001 · PubMed
  25. Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy
    Xueying Sun, Jagat R. Kanwar, Euphemia Yee Leung, Klaus Lehnert, D Wang, G W Krissansen · 2001 · Gene Therapy
  26. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
    Fumihiko Matsuno, Yuro Haruta, M Kondo, Hilda Tsai, Maurice P Barcos, Ben K. Seon · 1999 · PubMed
  27. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary.
    Lawrence P. Reynolds, Dale A. Redmer · 1998 · Journal of Animal Science
  28. Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy
    Peter Vajkoczy, Michael Dieter Menger, Brigitte Vollmar, Lothar Schilling, Peter Schmiedek, K. Peter Hirth, Axel Ullrich, T. Annie T. Fong · 1999 · Neoplasia
  29. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
    Masakazu Toi, Shinichi Kondo, Hideo Suzuki, Yutaka Yamamoto, Kazuo Inada, Takashi Imazawa, Tadaaki Taniguchi, Takeshi Tominaga · 1996 · Cancer
  30. Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
    Damilohun Samuel Metibemu, Oluseyi Adeboye Akinloye, Adio Jamiu Akamo, David Ajiboye Ojo, Tolulope Olamide Okeowo, Olaposi Idowu Omotuyi · 2019 · Egyptian Journal of Medical Human Genetics
  31. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
    Hans Hawighorst, Paul Georg Knapstein, Michael Vinzenz Knopp, W. Weikel, Gunnar Brix, IVAN ZUNA, SO Schönberg, Marco Essig, Peter W. Vaupel, GERHARD VAN KAICK · 1998 · PubMed
  32. Antiangiogenic cancer therapy
    Yihai Cao · 2004 · Seminars in Cancer Biology
  33. Effect of the vascular endothelial growth factor receptor‐2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice
    Christiane J. Bruns, Marissa Shrader, Matthew T. Harbison, Charles A. Portera, Carmen C. Solórzano, K.‐W. Jauch, Daniel J. Hicklin, Robert Radinsky, Lee M. Ellis · 2002 · International Journal of Cancer
  34. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
    Walter Kölch, Georg Martiny‐Baron, Arnd Kieser, Dieter Marm� · 1995 · Breast Cancer Research and Treatment
  35. Essential Roles of EphB Receptors and EphrinB Ligands in Endothelial Cell Function and Angiogenesis
    Ombretta Salvucci, Giovanna Tosato · 2012 · Advances in cancer research
  36. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
    Tobiloba Elebiyo, Damilare Emmanuel Rotimi, Ikponmwosa Owen Evbuomwan, Rotdelmwa Filibus Maimako, Matthew Eboseremen Iyobhebhe, Oluwafemi Adeleke Ojo, Olarewaju M. Oluba, Oluyomi Stephen Adeyemı · 2022 · Cancer Treatment and Research Communications
  37. In vitro and in vivo studies of a VEGF 121 /rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors
    Liesbeth M. Veenendaal, Hangqing Jin, Sophia Ran, Lawrence H. Cheung, Nora Maria Navone, John W. Marks, Johannes L. Waltenberger, Philip E. Thorpe, Michael G. Rosenblum · 2002 · Proceedings of the National Academy of Sciences
  38. Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.
    Seock‐Ah Im, Candelaria Gomez‐Manzano, Juan Fueyo-Margareto, Ta Jen Liu, Ke Li, Jeong Soo Kim, Ho‐Young Lee, Peter A. Steck, Athanassios P. Kyritsis, W. K. Alfred Yung · 1999 · PubMed
  39. Anti-VEGF therapy in pituitary carcinoma
    León Darío Ortiz, Luis V. Syro, Bernd Walter Scheithauer, Ayça Erşen, Humberto Uribe, Camilo E. Fadul, Fabio Rotondo, Éva Horváth, Kálmán Kovács · 2011 · Pituitary
  40. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy
    Duo Zhang, Albert Mao Li, Guanghui Hu, Menggui Huang, Fan Yang, Lin Zhang, Kathryn E. Wellen, Xiaowei Xu, Crystal S. Conn, Wei Zou et al. · 2023 · Cell Metabolism
  41. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas.
    Yasuhiko Kitadai, Ken Haruma, Tadashi Tokutomi, Shogo Tanaka, K Sumii, Maria João Carvalho, M Kuwabara, Kazuhiro Yoshida, Toshihiro Hirai, Goro Kajiyama et al. · 1998 · PubMed
  42. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas
    Steven N. Kalkanis, Rona Stephanie Carroll, Jianping Zhang, Amir A. Zamani, Peter McL. Black · 1996 · Journal of neurosurgery
  43. Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development
    Yuchen Liu, Luming Zhao, Dameng Li, Yuan Yin, Chen‐Yu Zhang, Jing Li, Yujing Zhang · 2013 · Protein & Cell
  44. Role of tumor vascular architecture in drug delivery
    Ajit S. Narang, Sailesh A. Varia · 2011 · Advanced Drug Delivery Reviews
  45. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.
    Qizhen Cao, Zhibin Lin · 2004 · PubMed
  46. Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts
    John Strugar, Gregory R. Criscuolo, David Rothbart, William N. Harrington · 1995 · Journal of neurosurgery
  47. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB: implications for angioprevention and antiangiogenic therapy
    Rana Pratap Singh, Sivanandhan Dhanalakshmi, Chapla Agarwal, Rajesh Agarwal · 2004 · Oncogene
  48. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
    ME Harper, Eveline Glynne-Jones, Lindy Goddard, Valerie Thurston, K. Griffiths · 1996 · British Journal of Cancer
  49. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Koichi Takayama, Hideki Ueno, Yoichi Nakanishi, T Sakamoto, K Inoue, Kana Shimizu, H Oohashi, Nobuyuki Hara · 2000 · PubMed
  50. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
    S. P. Dobbs, PW Hewett, IR Johnson, J Carmichael, JC Murray · 1997 · British Journal of Cancer
  51. Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor
    K. Reynolds, Farzin Farzaneh, William P. Collins, Stuart C. Campbell, Tom Bourne, F. E. Lawton, Amir Moghaddam, Adrian Llewellyn Harris, Roy Bicknell · 1994 · JNCI Journal of the National Cancer Institute
  52. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy
    Dan Lü, Xenia Jimenez, Haifan Zhang, Peter Böhlen, Larry Witte, Zhenping Zhu · 2001 · International Journal of Cancer
  53. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Gerhard Siemeister, Michael Schirner, Karin Weindel, Petra Reusch, Andreas Menrad, Dieter Marmé, Georg Martiny‐Baron · 1999 · PubMed
  54. Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?
    Ana A. Baburamani, Carl Joakim Ek, David W. Walker, Margie Castillo-Meléndez · 2012 · Frontiers in Physiology
  55. RGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathway
    Xiaoyan Fu, Yahui Yang, Xiaoling Li, Haoqiang Lai, Yanyu Huang, Lizhen He, Wenjie Zheng, Tianfeng Chen · 2016 · Nanomedicine Nanotechnology Biology and Medicine
  56. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting
    Andréas Bikfalvi, Roy Bicknell · 2002 · Trends in Pharmacological Sciences
  57. Differential Binding Characteristics and Cellular Inhibition by Soluble VEGF Receptors 1 and 2
    Wolfgang Röckl, Dalit Hecht, Helena Sztajer, Johannes L. Waltenberger, Avner Yayon, Herbert A. Weich · 1998 · Experimental Cell Research
  58. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair
    Janette M. Krum, Alfia Khaibullina · 2003 · Experimental Neurology
  59. ZD6474, a Potent Inhibitor of Vascular Endothelial Growth Factor Signaling, Combined With Radiotherapy
    Kaye Janine Williams, Brian A. Telfer, Sandra R. Brave, Jane Kendrew, Lynsey Whittaker, Ian James Stratford, Stephen R. Wedge · 2004 · Clinical Cancer Research
  60. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
    Gabriella Fontanini, Pinuccia Faviana, Marco Lucchi, Laura Boldrini, Alfredo Mussi, Tiziano Camacci, M A Mariani, C A Angeletti, Fulvio Basolo, R Pingitore · 2002 · British Journal of Cancer
  61. Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues
    Richard L. Kendall, Ruth Z. Rutledge, Xianzhi Mao, Andrew J. Tebben, Randall W. Hungate, Kenneth A. Thomas · 1999 · Journal of Biological Chemistry
  62. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways
    Rodrigue Romon, Éric Adriaenssens, Chann H. Lagadec, Emmanuelle Germain, Hubert Hondermarck, Xuefen Le Bourhis · 2010 · Molecular Cancer
  63. p38 Signaling-mediated Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor Induction by Cr(VI) in DU145 Human Prostate Carcinoma Cells
    Ning Gao, Bing‐Hua Jiang, Stephen S. Leonard, Linda Corum, Zhuo Zhang, Jenny R. Roberts, Jim M. Antonini, Jenny Z. Zheng, Daniel C. Flynn, Vince Castranova et al. · 2002 · Journal of Biological Chemistry
  64. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.
    O.O. Melnyk, Marc A. Shuman, K J Kim · 1996 · PubMed
  65. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
    Ji‐Liang Li · 2009 · Frontiers in bioscience
  66. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
    Michael Borre, Benni Nerstrøm, Jens Overgaard · 2000 · PubMed
  67. Activated STAT3 is a mediator and biomarker of VEGF endothelial activation
    Shao-Hua Chen, Danielle A. Murphy, Wiem Lassoued, Gavin Thurston, Michael D. Feldman, William M. F. Lee · 2008 · Cancer Biology & Therapy
  68. New treatment strategies for malignant gliomas
    Sith Sathornsumetee, Jeremy N. Rich · 2006 · Expert Review of Anticancer Therapy
  69. Bevacizumab: An Angiogenesis Inhibitor with Efficacy in Colorectal and Other Malignancies
    Stacey D Zondor, Patrick J. Medina · 2004 · Annals of Pharmacotherapy
  70. Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications
    Ramez Nassef Eskander, Krishnansu S. Tewari · 2013 · Gynecologic Oncology
  71. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis
    Weidong-Richard Ji, Francis Castellino, Yuan Chang, Melanie E. DeFord, Hilary Gray, Xavier C. Villarreal, Mohammad Eghtedarzadeh-Kondri, Daniel N. Marti, Miguel Llinás, Johann Schaller et al. · 1998 · The FASEB Journal
  72. Angiogenesis in cancer: molecular mechanisms, clinical impact
    Martin Eichhorn, Axel Kleespies, Martin Kurt Angele, K.‐W. Jauch, Christiane J. Bruns · 2007 · Langenbeck s Archives of Surgery
  73. Vascular targeting—a new approach to the therapy of solid tumors
    Francis J. Burrows, Philip E. Thorpe · 1994 · Pharmacology & Therapeutics
  74. Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells.
    Naokatu Arakaki, Tomoko Nagao, 仁木理恵, Ayako Toyofuku, Hiroaki Tanaka, Yoshinori Kuramoto, Yuka Emoto, Hirofumi Shibata, Koji Magota, Tomihiko Higuti · 2003 · PubMed
  75. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis
    Einar K. Rofstad, Turi Danielsen · 1999 · British Journal of Cancer
  76. A research shortcut from a common cold virus to human cancer
    Ed Harlow · 1996 · Cancer
  77. Angiogenesis in Embryos and Ischemic Diseases
    Georg Breier, Annette Damert, Karl Heinz Plate, Werner Risau · 1997 · Thrombosis and Haemostasis
  78. Tumor Angiogenesis and Anti-angiogenic Therapy
    Yoshiaki Kubota · 2012 · The Keio Journal of Medicine
  79. The dark side of tumor-associated endothelial cells
    Francesco De Sanctis, Stefano Ugel, John G. Facciponte, Andrea Facciabene · 2018 · Seminars in Immunology
  80. Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma
    Noriharu Shijubo, TOSHIMITSU UEDE, SHIGEYUKI KON, MASAHIRO MAEDA, TATSUYA SEGAWA, Akihiro Imada, MICHIO HIRASAWA, SHOSAKU ABE · 1999 · American Journal of Respiratory and Critical Care Medicine
  81. Sheet migration by wounded monolayers as an emergent property of single-cell dynamics
    Michael Bindschadler, James L. McGrath · 2007 · Journal of Cell Science
  82. IGF-1 and Retinopathy of Prematurity in the Preterm Infant
    Lois E. H. Smith · 2005 · Neonatology
  83. Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1
    Andrew C. Lake, Roger Vassy, Mélanie Di Benedetto, Damien Lavigne, Catherine Le Visage, Gérard Yves Perret, Didier Letourneur · 2006 · Journal of Biological Chemistry
  84. Cell-Extracellular Matrix Interaction in Glioma Invasion
    Roland Goldbrunner, J. J. Bernstein, Joerg‐Christian Tonn · 1999 · Acta Neurochirurgica
  85. URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES
    JEREMY P. CREW, TIM O'BRIEN, Roy Bicknell, Sue Fuggle, David Cranston, Adrian Llewellyn Harris · 1999 · The Journal of Urology
  86. Cellular and Molecular Abnormalities in the Vascular Endothelium of Diabetes Mellitus
    George Liang King, Teruo Shiba, Francisco Javier Oliver, Toyoshi Inoguchi, Sven–Erik Bursell · 1994 · Annual Review of Medicine
  87. Endothelial cell toll‐like receptor 4 regulates fibrosis‐associated angiogenesis in the liver†
    Kumaravelu Jagavelu, Chittaranjan Routray, Uday Shergill, Steven P. O’Hara, William Faubion, Vijay H. Shah · 2010 · Hepatology
  88. Cartilage to bone—Angiogenesis leads the way
    Jay W. Harper, Michael Klagsbrun · 1999 · Nature Medicine
  89. Inhibitory Effects of Artesunate on Angiogenesis and on Expressions of Vascular Endothelial Growth Factor and VEGF Receptor KDR/flk-1
    Huanhuan Chen, Huijun Zhou, Guo-Dong Wu, Xiao-E Lou · 2004 · Pharmacology
  90. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
    Erika Hatva, Tom Böhling, Juha E. Jääskeläinen, Maria Graziella Persico, Matti Haltia, Kari K. Alitalo · 1996 · Europe PMC (PubMed Central)
  91. Prostaglandins Induce Vascular Endothelial Growth Factor in a Human Monocytic Cell Line and Rat Lungs via cAMP
    Marius M. Höper, Norbert Felix Voelkel, Thomas O. Bates, Jenny D. Allard, Marilee P. Horan, David Shepherd, Rubin M. Tuder · 1997 · American Journal of Respiratory Cell and Molecular Biology
  92. Fractal characterization of chromatin appearance for diagnosis in breast cytology
    Andrew Jeffrey Einstein, Haishan Wu, Miguel A. Sánchez, Joan Gil · 1998 · The Journal of Pathology
  93. Proximity ligation assays for sensitive and specific protein analyses
    Sigrun Gustafsdottir, Edith Schallmeiner, Simon Fredriksson, Mats T. Gullberg, Ola Söderberg, Malin Jarvius, Jonas Jarvius, Mathias Howell, Ulf D. Landegren · 2005 · Analytical Biochemistry
  94. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice.
    Karen Smith‐McCune, Y H Zhu, Douglas Hanahan, Jeffery M. Arbeit · 1997 · PubMed
  95. Vascular Endothelial Growth Factor Trap Combined with Paclitaxel Strikingly Inhibits Tumor and Ascites, Prolonging Survival in a Human Ovarian Cancer Model
    Limin Hu, Judith Hofmann, Jocelyn A. Holash, George D. Yancopoulos, Anil K. Sood, Robert B. Jaffe · 2005 · Clinical Cancer Research
  96. Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma
    Max L. Tejada, Lanlan Yu, Jianying Dong, Kenneth Jung, Gloria Meng, Franklin V. Peale Jr., Gretchen D. Frantz, Linda Hall, Xiao‐Huan Liang, Hans‐Peter Gerber et al. · 2006 · Clinical Cancer Research
  97. Localized paclitaxel delivery
    Anand Babu Dhanikula, Ramesh Panchagnula · 1999 · International Journal of Pharmaceutics
  98. Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study
    Martee Leigh Hensley, Austin Miller, David M. O’Malley, Robert S. Mannel, Kian Behbakht, Jamie Nadine Bakkum-Gamez, Helen Michael · 2015 · Journal of Clinical Oncology
  99. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.
    David T. Shima, Anne Gougos, Joan W. Miller, Michael J. Tolentino, G C ROBINSON, Anthony P. Adamis, Patrìcia A. D'Amore · 1996 · PubMed
  100. Vascular endothelial growth factor content in metastasizing and nonmetastasizing dunning prostatic adenocarcinoma
    Stina H�ggstr�m, Anders R. J. Bergh, Jan‐Erik Damber · 2000 · The Prostate